Stock DNLI DENALI THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Denali Therapeutics Inc.

Equities

DNLI

US24823R1059

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
19.3 USD +5.41% Intraday chart for Denali Therapeutics Inc. +12.60% -10.07%
May. 08 Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating MT
May. 08 Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
DENALI THERAPEUTICS INC.
Bio Therapeutic Drugs
+5.41%+12.60%-10.07%-30.97%-7.26% 2.61B
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. DNLI Stock
  4. Charts Denali Therapeutics Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW